How Type 2 Diabetes Is Diagnosed: 4 Key Tests

Type 2 diabetes is diagnosed through blood tests that measure how much sugar is in your blood, either at a single point in time or averaged over several months. There are four main tests used, each with a specific numerical threshold. In most cases, you’ll need two abnormal results to confirm the diagnosis, not just one.

The Four Diagnostic Tests

Each test measures blood sugar differently, and any one of them can be used to make a diagnosis. The thresholds that indicate diabetes are:

  • A1C test: 6.5% or higher. This reflects your average blood sugar over the past two to three months.
  • Fasting plasma glucose (FPG): 126 mg/dL or higher. This measures blood sugar after you haven’t eaten for at least 8 hours.
  • Oral glucose tolerance test (OGTT): 200 mg/dL or higher at the two-hour mark. You drink a solution containing 75 grams of sugar, then have your blood drawn one and two hours later.
  • Random plasma glucose: 200 mg/dL or higher, but only when you also have classic symptoms like frequent urination, excessive thirst, and unexplained weight loss.

Results that fall below the diabetes threshold but above normal may indicate prediabetes. On the A1C test, for example, prediabetes falls between 5.7% and 6.4%.

Why You Usually Need Two Abnormal Results

If you don’t have obvious symptoms of high blood sugar, a single abnormal test isn’t enough for a diagnosis. You need two abnormal results, either from the same blood sample (for instance, both an A1C and a fasting glucose drawn at the same visit) or from two separate visits. The second test can repeat the first one or use a different method.

If two different tests give conflicting results, your doctor will repeat whichever test came back above the diagnostic threshold. The diagnosis is confirmed based on the repeated test. This protocol exists because blood sugar can fluctuate for many reasons, and a single reading doesn’t always reflect what’s actually happening in your body long-term.

The one exception: if you have classic symptoms (frequent urination, excessive thirst, unexplained weight loss) and a random blood sugar of 200 mg/dL or higher, that single result is enough.

What Each Test Involves

The A1C test is the simplest from your perspective. It doesn’t require fasting, and it can be drawn at any time of day. Rather than capturing a snapshot of your blood sugar right now, it measures a form of hemoglobin that accumulates when blood sugar stays elevated over weeks and months. That longer window makes it useful for catching patterns that a single fasting test might miss.

The fasting plasma glucose test requires you to go without food or drink (other than plain water) for 8 to 12 hours before the blood draw. During the fast, you should also avoid chewing gum, smoking, and exercise, all of which can affect results. If you take prescription or over-the-counter medications, ask your doctor whether to take them as usual or skip them that morning.

The oral glucose tolerance test takes the most time. After fasting overnight, you’ll have a baseline blood draw, then drink a very sweet glucose solution. Blood is drawn again at one hour and two hours. The two-hour reading is the one used for diagnosis. This test is less commonly used for routine screening because it requires a longer office visit, but it can catch cases that fasting glucose or A1C miss.

When A1C Results Can Be Unreliable

The A1C test works by measuring changes to hemoglobin, the protein in red blood cells that carries oxygen. Anything that affects your red blood cells or hemoglobin can throw off the results. Iron deficiency anemia, for example, tends to push A1C readings artificially higher, which could lead to a false diagnosis. Conditions that shorten the lifespan of red blood cells, like hemolytic anemia or recovery from significant blood loss, pull A1C results in the opposite direction, making blood sugar look better controlled than it actually is.

People who carry sickle cell trait or other hemoglobin variants also need to interpret A1C results carefully. Chronic kidney disease, particularly in people on dialysis, can make A1C unreliable as well. In late pregnancy, iron deficiency alone can raise A1C in people who don’t have diabetes at all. If any of these apply to you, your doctor will likely rely on fasting glucose or the oral glucose tolerance test instead.

Who Should Get Screened

The U.S. Preventive Services Task Force recommends screening adults who are overweight or obese, with earlier screening for people who carry additional risk. That includes people who are American Indian/Alaska Native, Asian American, Black, Hispanic/Latino, or Native Hawaiian/Pacific Islander, as well as anyone with a family history of diabetes, a history of gestational diabetes, or polycystic ovarian syndrome. For Asian Americans specifically, screening is recommended at a lower BMI threshold of 23, compared to 25 for the general population.

Many people with type 2 diabetes have no symptoms at the time of diagnosis. The disease develops gradually, and blood sugar can be elevated for years before you notice anything wrong. That’s why routine screening based on risk factors matters more than waiting for symptoms to appear.

Telling Type 2 Apart From Type 1

The blood sugar tests above confirm that you have diabetes, but they don’t specify which type. In most adults, especially those who are overweight and have a gradual onset, type 2 is the presumed diagnosis. But when the picture is less clear, a C-peptide test can help sort things out. C-peptide is a byproduct of insulin production, so measuring it reveals how much insulin your pancreas is actually making. In type 2 diabetes, C-peptide levels are typically normal or high, reflecting a body that produces insulin but doesn’t use it efficiently. In type 1, C-peptide is low or undetectable because the insulin-producing cells have been destroyed.

This distinction matters because the two types require different treatment approaches. A small percentage of adults diagnosed with type 2 actually have a slow-progressing form of type 1 called latent autoimmune diabetes. C-peptide testing, sometimes combined with antibody tests, helps catch those cases before treatment stalls.